1. , . A study of the vessels of the placental bed in normotensive and hypertensive women. J Obstet Gynaecol Br Emp 1958; 65: 803–09.
2. . A Study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies. J Obstet Gynaecol Br Commonw 1964; 71: 222–30.
3. , . The maternal placental blood flow in normotensive and hypertensive women. J Obstet Gynaecol Br Emp 1953; 60: 141–7.
4. . Techniques for the study of the uteroplacental circulation. In: , ed. The uterine circulation. Ithaca, NY: Perinatology Press; 1989: pp. 35–51.
5. . Uteroplacental blood flow in pregnant women: its measurement by radioisotope techniques. In: , , eds. Uterine and placental blood flow. New York: Masson Publishing USA, Inc.; 1982: pp. 53–9.
6. , , . The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 1967; 93: 569–79.
7. , , . The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177–91.
8. . The uteroplacental vessels at term – the distribution and extent of physiological changes. Trophoblast Res 1988; 3: 61–7.
9. , , , . Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049–59.
10. , , . Defective haemochorial placentation as a cause of miscarriage: a preliminary study. Br J Obstet Gynaecol 1987; 94: 649–55.
11. , , , . A morphological and immunological study of human placental bed biopsies in miscarriage. Br J Obstet Gynaecol 1990; 97: 984–88.
12. , . Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 1992; 99: 651–54.
13. , , et al. The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 2006; 27: 457–67.
14. , , et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003; 189: 1063–69.
15. , , et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187: 1137–42.
16. . Prenatal medicine: the child is the father of the man. J Mat Fet Neonat Med, in press.
17. , , . Histological study of the materno-embryonic interface in spontaneous abortion. Placenta 1990; 11: 477–86.
18. , , . The comparison of vessels in elective and spontaneous abortion decidua in first trimester pregnancies: importance of vascular changes in early pregnancy losses. Acta Obstet Gynecol Scand 2006; 85: 402–6.
19. , , , , . Early embryonic demise: no evidence of abnormal spiral artery transformation or trophoblast invasion. J Pathol 2006; 208: 528–34.
20. , , , , . Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol 2006; 208: 535–42.
21. , , , . Epidemiology and causes of preterm birth. Lancet 2008; 371: 75–84.
22. , , et al. The preterm parturition syndrome. BJOG 2006; 113(Suppl 3): 17–42.
23. , . Amniotic fluid infection syndrome. Clin Obstet Gynaecol 1982; 9: 593–607.
24. . Prematurity: infection as an etiologic factor. Obstet Gynecol 1983; 62: 137–44.
25. , , et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12: 262–79.
26. , . Infection and preterm labor. Clin Obstet Gynecol 1988; 31: 553–84.
27. , , et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161: 817–24.
28. , , et al. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166: 1515–28.
29. , , . Intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500–7.
30. , , et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001; 185: 1130–36.
31. , , . Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002; 8: 3–13.
32. , , et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004; 191: 1339–45.
33. , , et al. Clinical significance of the presence of amniotic fluid ‘sludge’ in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obstet Gynecol 2007; 30: 706–14.
34. , , et al. What is amniotic fluid ‘sludge’?Ultrasound Obstet Gynecol 2007; 30: 793–98.
35. , , et al. Detection of a microbial biofilm in intraamniotic infection. Am J Obstet Gynecol 2008; 198: 135.
36. , , , . Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993; 168: 585–91.
37. , , , . Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet Gynecol 1997; 89: 265–71.
38. , , et al. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol 1995; 172: 1097–103.
39. , , et al. Patients with an ultrasonographic cervical length < or = 15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000; 182: 1458–67.
40. , , , . The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified?Am J Obstet Gynecol 2006; 194: 1–9.
41. , , , . Polyhydramnios and perinatal outcome. J Perinatol 1990; 10: 347–50.
42. , , et al. The preterm labor syndrome: biochemical, cytologic, immunologic, pathologic, microbiologic, and clinical evidence that preterm labor is a heterogeneous disease. Am J Obstet Gynecol 1993; 168(1 part 2): 287.
43. , , , , . Uterine “allergy”: a novel mechanism for preterm labor. Am J Obstet Gynecol 1991; 164(1 part 2): 375.
44. , , , , . Modulation of rat uterine contractility by mast cells and their mediators. Am J Obstet Gynecol 2000; 183: 118–25.
45. , , et al. Induction of premature labor and delivery by allergic reaction and prevention by histamine H1 receptor antagonist. Am J Obstet Gynecol 2004; 191: 1356–61.
46. , , . Progesterone deficiency and premature labour. Br Med J 1974; 1: 137–40.
47. , , , . Increased rate of preterm deliveries in untreated women with luteal phase deficiencies: preliminary report. Gynecol Obstet Invest 1992; 33: 183–84.
48. , , et al. Human preterm birth is associated with systemic and local changes in progesterone/17 beta-estradiol ratios. Am J Obstet Gynecol 1994; 171: 231–36.
49. , , , . Bacteria-induced or bacterial product-induced preterm parturition in mice and rabbits is preceded by a significant fall in serum progesterone concentrations. J Matern Fetal Med 1998; 7: 222–26.
50. , , et al. Preterm labor: placental pathology and clinical correlation. Obstet Gynecol 1999; 94: 284–89.
51. , , , . Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol 1993; 169: 215–23.
52. . Placental insufficiency: an important cause of preterm labor and preterm premature ruptured membranes. Society of Perinatal Obstetricians (10th Annual Meeting) 1990; 158.
53. , , , . Preterm premature rupture of the membranes: a risk factor for the development of abruptio placentae. Am J Obstet Gynecol 1987; 156: 1235–38.
54. , . Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1988; 159: 390–96.
55. , , . Preterm premature rupture of membranes and placental abruption: is there an association between these pregnancy complications?Am J Obstet Gynecol 1991; 164: 381.
56. , , , . Maternal and fetal blood flow velocity waveforms in patients with preterm labor: prediction of successful tocolysis. Am J Obstet Gynecol 1988; 159: 947–50.
57. , , , . Maternal and fetal blood flow velocity waveforms in patients with preterm labor: relationship to outcome. Am J Obstet Gynecol 1989; 161: 1519–22.
58. , , et al. Uterine artery velocimetry and spontaneous preterm delivery. Obstet Gynecol 1995; 85: 374–77.
59. , , , . A hypothetical model suggesting suboptimal intrauterine growth in infants delivered preterm. Obstet Gynecol 1985; 65: 323–26.
60. , , , , . Differing fetal growth patterns in pregnancies complicated by preterm labor. Obstet Gynecol 1988; 72: 834–37.
61. . Intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol 1993; 168: 1710–15.
62. , , , . The relationship between intrauterine growth restriction and preterm delivery: an empirical approach using data from a European case-control study. BJOG 2000; 107: 750–58.
63. , , , . Impairment of growth in fetuses destined to deliver preterm. Am J Obstet Gynecol 2001; 185: 463–67.
64. , , . Fetal growth and onset of delivery: a nationwide population-based study of preterm infants. Am J Obstet Gynecol 2006; 195: 154–61.
65. , , et al. An episode of preterm labor is a risk factor for the birth of a small-for-gestational-age neonate. Am J Obstet Gynecol 2007; 196: 574–75.
66. . The human placental renin-angiotensin system. Front Neuroendocrinol 1998; 19: 232–52.
67. , , , , . Uterine and renal renin release after ligation of the uterine arteries in the pregnant rabbit. Am J Obstet Gynecol 1980; 136: 676–78.
68. , . Role of the renin-angiotensin system in hypertension during reduced uteroplacental perfusion pressure. Am J Physiol 1989; 257: R204–R209.
69. , , , . Contractions of rat uterine smooth muscle induced by acetylcholine and angiotensin II in Ca2+-free medium. Br J Pharmacol 1984; 81: 317–26.
70. , , . Angiotensin II induced release of prostaglandins from rat uterus. Arch Biol Med Exp (Santiago) 1983; 16: 43–9.
71. , , et al. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation. Ann N Y Acad Sci 1994; 734: 57–79.
72. , , , . Effects of thrombin on myometrial contractions in vitro and in vivo. Am J Obstet Gynecol 2000; 183: 799–804.
73. , , et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002; 11: 11–17.
74. , , , . Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. J Clin Endocrinol Metab 1996; 81: 107–12.
75. . Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mos.) 2002; 67: 92–8.
76. , , . The extracellular matrix of human amniotic epithelium: ultrastructure, composition and deposition. J Cell Sci 1985; 79: 119–36.
77. , , et al. Activation of coagulation system in preterm labor and preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002; 11: 368–73.
78. , , et al. Increased thrombin in intrauterine inflammation. Am J Obstet Gynecol 1998; 178: S62.
79. , , , , . Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001; 10: 297–300.
80. , , , , . Clinical significance of subchorionic and retroplacental hematomas detected in the first trimester of pregnancy. Obstet Gynecol 2003; 102: 94–100.
81. , , . Outcome of pregnancies complicated by early vaginal bleeding. Br J Obstet Gynaecol 1980; 87: 100–5.
82. , , , . Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstet Gynecol 1991; 78: 14–18.
83. , , . Second-trimester vaginal bleeding: correlation of ultrasonographic findings with perinatal outcome. Am J Obstet Gynecol 1998; 178: 336–40.
84. , , et al. Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. J Matern Fetal Neonatal Med 2005; 18: 31–7.
85. , . Placental abruption and perinatal mortality in the United States. Am J Epidemiol 2001; 153: 332–37.
86. , , , . Chorionic villous haemorrhage is associated with retroplacental haemorrhage. Br J Obstet Gynaecol 1994; 101: 965–69.
87. , , , . Antiphospholipid antibodies and fetal loss. N Engl J Med 1992; 326: 952–54.
88. , , et al. Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy. Am J Obstet Gynecol 2003; 188: 454–60.
89. , , , . Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med 1980; 303: 668–72.
90. , , et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829–34.
91. , , , . Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41: 179–86.
92. , , et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112: 1644–54.
93. , , . Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004; 10: 1222–26.
94. , , et al. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002; 17: 1067–71.
95. , , et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–42.
96. , , , . Studies on experimental growth retardation in sheep: the effect of removal of endometrial caruncles on fetal size and metabolism. J Dev Physiol 1979; 1: 379–98.
97. , , , , . Studies on the growth of the fetal sheep. The effects of reduction of placental size on hormone concentration in fetal plasma. J Dev Physiol 1980; 2: 239–48.
98. , , , . Effect of restriction of placental growth on the concentrations of insulin, glucose and placental lactogen in the plasma of sheep. J Endocrinol 1985; 106: 7–11.
99. , , et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. Am J Obstet Gynecol 1993; 169: 798–804.
100. , , et al. The length of the cervix and the risk of spontaneous premature delivery: National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Eng J Med 1996; 334: 567–72.
101. , , et al. The preterm prediction study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1997; 177: 8–12.
102. , . Sonographic measurement of uterine cervix at 18–22 weeks’ gestation and the risk of preterm delivery. Obstet Gynecol 1998; 92: 902–07.
103. , , et al. Second-trimester cervical ultrasound: associations with increased risk for recurrent early spontaneous delivery. Obstet Gynecol 2000; 95: 222–26.
104. , , et al. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000; 182: 636–43.
105. , , , , . Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery. BJOG 2000; 107: 1276–81.
106. , , , , . Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery. Ultrasound Obstet Gynecol 2001; 18: 200–3.
107. , , et al. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety. BJOG 2005; 112: 293–98.
108. , , et al. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006; 34: 13–19.
109. , , et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16–20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983; 10: 294–302.
110. , , , . Adverse outcome in pregnancy following amniotic fluid isolation of Ureaplasma urealyticum. Prenat Diagn 1992; 12: 111–17.
111. , , , , . Infection of the amniotic cavity with Ureaplasma urealyticum in the midtrimester of pregnancy. J Reprod Med 1995; 40: 375–79.
112. , , , . Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis 2003; 187: 518–21.
113. , , , , . Mycoplasma hominis in mid-trimester amniotic fluid: relation to pregnancy outcome. J Perinat Med 2004; 32: 323–26.
114. , , , , . Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. Br J Obstet Gynaecol 1996; 103: 54–9.
115. , . Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol 2007; 109: 1205–6.
116. , , et al. A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne’s syndrome). J Matern Fetal Neonatal Med 2006; 19: 607–13.
117. , , et al. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol 2007; 109: 549–52.
118. , , , , . A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682–89.
119. , , , . The nature of pressor responsiveness to angiotensin II in human pregnancy. Obstet Gynecol 1974; 43: 854.
120. , , , . Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. Eur J Obstet Gynecol Reprod Biol 1991; 42(Suppl): S14–S20.
121. , , . Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993; 82: 78–83.
122. , , , , . Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational-age baby. Ultrasound Obstet Gynecol 1996; 7: 182–88.
123. , , , . Prediction of pre-eclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women. Br J Obstet Gynaecol 1998; 105: 422–29.
124. , , et al. Quantification of the diastolic notch in Doppler ultrasound screening of uterine arteries. Ultrasound Obstet Gynecol 2000; 16: 630–34.
125. , , , , . One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’ gestation. Obstet Gynecol 2000; 96: 559–64.
126. , , , , . How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG 2000; 107: 196–208.
127. , , et al. Individualized risk assessment for adverse pregnancy outcome by uterine artery Doppler at 23 weeks. Obstet Gynecol 2001; 98: 369–73.
128. , , , , . Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 441–49.
129. , , , , . Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002; 12: 78–88.
130. , , , , . Screening for pre-eclampsia and fetal growth restriction in twin pregnancies at 23 weeks of gestation by transvaginal uterine artery Doppler. Ultrasound Obstet Gynecol 2002; 20: 535–40.
131. , , , , . Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG 2005; 112: 703–9.
132. , , , , . An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005; 193: 429–36.
133. , , et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1–326.e13.
134. , , , , . Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008; 32: 138–46.
135. , , et al. Placenta growth factor is not an early marker for the development of severe preeclampsia. Am J Obstet Gynecol 2001; 184: 1218–20.
136. , , et al. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol 2001; 97: 898–904.
137. , , , , . Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001; 184: 1267–72.
138. , , et al. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001; 98: 600–7.
139. , , et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127–36.
140. , , et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177–82.
141. , , . Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 2004; 23: 101–11.
142. , , et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672–83.
143. , , et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770–75.
144. , , et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005; 17: 3–18.
145. , , et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005; 193: 1486–91.
146. , , et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992–1005.
147. , , et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007; 197: 244–48.
148. , , et al. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007; 30: 151–59.
149. , . Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol 2007; 197: 174–75.
150. , , , . Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007; 49: 818–24.
151. , , , . Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. Am J Obstet Gynecol 2007; 197: 211–14.
152. , , , , . Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008; 32: 732–39.
153. , , et al. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008; 199: 266.
154. , , et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31: 303–9.
155. , , et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008; 21: 279–87.
156. , , et al. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol 2008; 111: 1403–9.
157. , , et al. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 2008; 198: 175–76.
158. , , et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol 2006; 27: 13–17.
159. , , et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007; 197: 35–7.
160. , , et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. BJOG 2008; 115: 1465–72.
161. , , et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 2008; 199: 122.
162. , , et al. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn, in press.
163. , , . Abnormal uterine artery Doppler in small-for-gestational-age pregnancies is associated with later hypertension. Aust N Z J Obstet Gynaecol 2001; 41: 56–60.
164. . On the pathogenesis of pre-eclampsia and eclampsia. J Obstet Gynaecol Br Commonw 1972; 79: 883–94.
165. , . Familial aspects of pre-eclampsia and hypertension in pregnancy. Lancet 1961; 2: 1375–78.
166. , , . The familial factor in toxemia of pregnancy. Obstet Gynecol 1968; 32: 303–11.
167. , . Genetic control of severe pre-eclampsia. J Med Genet 1979; 16: 409–16.
168. , , , , . The indicence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls. BJOG 1981; 88: 785–91.
169. , , et al. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. BJOG 1990; 97: 762–69.
170. . Prenatal influences and endothelial dysfunction: a link between reduced placental perfusion and preeclampsia. Hypertension 2007; 49: 775–76.
171. , , et al. A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 1997; 60: 1158–67.
172. , , et al. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet 1999; 8: 1799–805.
173. , , et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 2000; 67: 1581–85.
174. , , et al. A genome-wide scan for preeclampsia in the Netherlands. Eur J Hum Genet. 2001; 9: 758–64.
175. , , et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet. 2003; 72: 168–77.
176. , , et al. Genome-wide scan for premature hypertension supports linkage to chromosome 2 in a large Kyrgyz family. Hypertension 2006; 48: 908–13.
177. , , et al. Objective prioritization of positional candidate genes at a quantitative trait locus for pre-eclampsia on 2q22. Mol Hum Reprod 2006; 12: 505–12.
178. , , et al. Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach. Mol Hum Reprod 2007; 13: 61–67.
179. , , et al. Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered 2007; 63: 1–16.
180. , , et al. Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia. BMC Med Genet 2008; 9: 60.
181. , , et al. Risk factors for severe preeclampsia. Obstet Gynecol 1994; 83: 357–61.
182. , , et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995; 172: 642–48.
183. , , . Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003; 14: 368–74.
184. , , , . The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15: 475–82.
185. , , , , . Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 2007; 18: 234–39.
186. , , , , . A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994; 171: 158–64.
187. , , , , . Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia. Am J Obstet Gynecol 2000; 182: 351–57.
188. , , . Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008; 198: 7–22.